Toward a National Pharmaceuticals Strategy: Lessons from Abroad

2 006

Vancouver, BC
February 9, 2006 to February 10, 2006

Pharmaceutical policy has become one of the most important and hotly contested domains of health system management--a rise in prominence largely due to financial realities. Costing over $24 billion, prescription drugs are second only to hospitals in terms of health care spending in Canada. CHSPR’s 18th health policy conference, Toward a National Pharmaceuticals Strategy, brought together leading international pharmaceutical policy experts to tackle some of the most pressing issues in global health care--including evidence and values in drug coverage decisions, drug safety and post-marketing surveillance, national formularies and expenditure management.